278 related articles for article (PubMed ID: 17971598)
1. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.
Pöttgen C; Eberhardt W; Grannass A; Korfee S; Stüben G; Teschler H; Stamatis G; Wagner H; Passlick B; Petersen V; Budach V; Wilhelm H; Wanke I; Hirche H; Wilke HJ; Stuschke M
J Clin Oncol; 2007 Nov; 25(31):4987-92. PubMed ID: 17971598
[TBL] [Abstract][Full Text] [Related]
2. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
[TBL] [Abstract][Full Text] [Related]
3. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
Weitberg AB; Liu L; Yashar J; Glicksman AS
J Exp Clin Cancer Res; 2001 Sep; 20(3):335-40. PubMed ID: 11718211
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of prophylactic cranial irradiation for limited-stage small-cell lung cancer in complete remission.
Cao KJ; Huang HY; Tu MC; Pan GY
Chin Med J (Engl); 2005 Aug; 118(15):1258-62. PubMed ID: 16117878
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.
Edelman MJ; Suntharalingam M; Burrows W; Kwong KF; Mitra N; Gamliel Z; Riley M; Cooper LB; Kennedy NL; Buskirk S; Hausner P; Doyle LA; Krasna MJ
Ann Thorac Surg; 2008 Sep; 86(3):903-10. PubMed ID: 18721580
[TBL] [Abstract][Full Text] [Related]
6. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y
Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299
[TBL] [Abstract][Full Text] [Related]
7. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
[TBL] [Abstract][Full Text] [Related]
8. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H
Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612
[TBL] [Abstract][Full Text] [Related]
9. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A
J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491
[TBL] [Abstract][Full Text] [Related]
10. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
Mamon HJ; Yeap BY; Jänne PA; Reblando J; Shrager S; Jaklitsch MT; Mentzer S; Lukanich JM; Sugarbaker DJ; Baldini EH; Berman S; Skarin A; Bueno R
J Clin Oncol; 2005 Mar; 23(7):1530-7. PubMed ID: 15735128
[TBL] [Abstract][Full Text] [Related]
11. [Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
Sawa T; Yoshida T; Ishiguro T; Ogawara M; Kawahara M; Yamamoto S; Yokota S; Maeda H; Asamoto H
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1745-9. PubMed ID: 14619509
[TBL] [Abstract][Full Text] [Related]
12. The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study.
Rusch VW; Griffin BR; Livingston RB
J Thorac Cardiovasc Surg; 1989 Oct; 98(4):535-9. PubMed ID: 2552227
[TBL] [Abstract][Full Text] [Related]
13. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
[TBL] [Abstract][Full Text] [Related]
14. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
[TBL] [Abstract][Full Text] [Related]
15. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).
Eberhardt WE; Gauler TC; Lepechoux C; Stamatis G; Bildat S; Krbek T; Welter S; Grunenwald D; Fischer B; Rodrigo Hde L; Theegarten D; Le Chevalier T; Seeber S; Stuschke M; Poettgen C
Lung Cancer; 2013 Oct; 82(1):83-9. PubMed ID: 23957964
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
Patel S; Macdonald OK; Suntharalingam M
Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.
Stuschke M; Eberhardt W; Pöttgen C; Stamatis G; Wilke H; Stüben G; Stöblen F; Wilhelm HH; Menker H; Teschler H; Müller RD; Budach V; Seeber S; Sack H
J Clin Oncol; 1999 Sep; 17(9):2700-9. PubMed ID: 10561344
[TBL] [Abstract][Full Text] [Related]
18. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
Park BB; Park JO; Kim H; Ahn YC; Choi YS; Kim K; Kim J; Shim YM; Ahn JS; Park K
Lung Cancer; 2006 Sep; 53(3):323-30. PubMed ID: 16844258
[TBL] [Abstract][Full Text] [Related]
19. A single institutional subset analysis of the WJLCG study comparing concurrent and sequential chemoradiotherapy for stage III non-small-cell lung cancer.
Tada T; Minakuchi K; Matsui K; Kin H; Nishiguchi T; Fukuda H
Radiat Med; 2004; 22(3):163-7. PubMed ID: 15287531
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review.
Lester JF; MacBeth FR; Coles B
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):690-4. PubMed ID: 15913909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
